COVID-19 (Coronavirus) Update: Testing and Information | Vaccine Updates | Visitor Guidelines

MolecularTemplates-MT-3724: Safety, Pharmacodynamics and Efficacy of MT-3724 for the Treatment of Patients with Relapsed or Refractory DLBCL (MT-3724-NHL-001)

Protocol No
MOLECULARTEMPLATES-MT-3724-NHL
Principal Investigator
Nirav Shah
Phase
II
Summary
The purpose of this research study is to examine the safety of MT-3724 and how well it works against DLBCL. In addition, the study will explore the pharmacokinetics (PK) of MT-3724 (how the body processes the study drug) and the pharmacodynamics (PD) of MT-3724 (how the study drug affects the body).
Description
Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL (MT-3724NHL001)
Participating Institutions
Froedtert Hospital
Status
ON HOLD